Advances in Pharmacoepidemiology and Drug Safety

Advances in Pharmacoepidemiology and Drug Safety
Open Access

ISSN: 2167-1052

+3225885717

Editorial Board

Richard L Slaughter
Editor-in-Chief
Professor, Department of Pharmacy Practise
Wayne State University, USA

Victor P Andreev, PhD
Executive Editor
Associate Professor, Department of Psychiatry and Behavioral Sciences
UNIVERSITY OF MIAMI, USA

Dr. Amgad M. Rabie, PhD
Executive Editor
Professor & Researcher of Medicinal Chemistry & Drug Discovery
Mansoura University, Egypt

Submit Manuscript

Journal Impact Factor 1.5 (5 Years)*
Submit manuscript at www.longdom.org/submissions/advances-pharmacoepidemiology-drug-safety.html or send as an e-mail attachment to the Editorial Office at [email protected]

About the Journal

Index Copernicus Value: 82.47 NLM ID: 101607843

• Advances in Pharmacoepidemiology and Drug Safety is a peer-reviewed open access journal focusing on studies pertaining to rare adverse drug reactions, drug efficacy evaluations, drug interaction quantifications, patterns of drug usage, herbal medicines, randomized control trials, case control studies, cross-sectional studies, case cross over studies and cohort studies.

• The journal also serves as a compendium of knowledge in pharmacoepidemiology and drug safety which can be readily accessed by physicians, surgeons, medical scientists, public health professionals, medical students, clinicians, lab researchers, academicians and industry for keeping themselves updated and also to formulate further research programs.

• The journal regularly publishes reports covering wide range of topics which include new challenges of over drug use, insufficient use and inappropriate use of drugs; Pharmacoepidemiology; improvements in molecular biology techniques and identification of the genetic determinants of drug effects.

Journal Highlights

Top